IPHA

Innate Pharma

9 hedge funds and large institutions have $255K invested in Innate Pharma in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
ETC
1
Exchange Traded Concepts
Oklahoma
$143K
Morgan Stanley
2
Morgan Stanley
New York
$80.1K
Citadel Advisors
3
Citadel Advisors
Florida
$21.9K -$17.4K -9,414 -44%
UBS Group
4
UBS Group
Switzerland
$6.46K -$9.01K -4,898 -58%
RhumbLine Advisers
5
RhumbLine Advisers
Massachusetts
$1.25K +$869 +470 +229%
Barclays
6
Barclays
United Kingdom
$1K
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
$828 +$828 +450 New
SPIA
8
Steward Partners Investment Advisory
New York
$368
Optiver Holding
9
Optiver Holding
Netherlands
$187 -$161K -86,687 -100%